Shilpa Medicare directed to to pay damage to Celltrion
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
The matter of Arbitration between Shilpa Medicare Limited and Celltrion towards supply and distribution agreement
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Growth team leads financing round in Cleveland Diagnostics; company to advance novel blood-based diagnostic technology to improve and lower costs for patients with cancer
Produodopa is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of severe motor fluctuations
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Inducts advanced AI-Powered 24x7 remote patient monitoring system
Subscribe To Our Newsletter & Stay Updated